RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 127 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $993,065 | -12.7% | 43,318 | -37.2% | 0.00% | 0.0% |
| Q2 2023 | $1,137,827 | +15.4% | 69,001 | +24.8% | 0.00% | 0.0% |
| Q1 2023 | $986,392 | -28.6% | 55,291 | +16.6% | 0.00% | 0.0% |
| Q4 2022 | $1,380,637 | +58.9% | 47,412 | +33.6% | 0.00% | 0.0% |
| Q3 2022 | $869,000 | +752.0% | 35,484 | +44.7% | 0.00% | – |
| Q2 2022 | $102,000 | -67.5% | 24,522 | -10.1% | 0.00% | – |
| Q1 2022 | $314,000 | +11.0% | 27,271 | -4.0% | 0.00% | – |
| Q4 2021 | $283,000 | -15.5% | 28,417 | +11.1% | 0.00% | – |
| Q3 2021 | $335,000 | -28.3% | 25,580 | +7.5% | 0.00% | – |
| Q2 2021 | $467,000 | -13.7% | 23,802 | -6.5% | 0.00% | – |
| Q1 2021 | $541,000 | -58.9% | 25,456 | -42.5% | 0.00% | -100.0% |
| Q4 2020 | $1,317,000 | +256.9% | 44,276 | +159.5% | 0.00% | – |
| Q3 2020 | $369,000 | -55.3% | 17,060 | -54.0% | 0.00% | -100.0% |
| Q2 2020 | $826,000 | +284.2% | 37,053 | +162.1% | 0.00% | – |
| Q1 2020 | $215,000 | -38.0% | 14,138 | -6.7% | 0.00% | – |
| Q4 2019 | $347,000 | +42.2% | 15,152 | +34.0% | 0.00% | – |
| Q3 2019 | $244,000 | -21.5% | 11,306 | -20.3% | 0.00% | – |
| Q2 2019 | $311,000 | +19.2% | 14,183 | +48.7% | 0.00% | – |
| Q1 2019 | $261,000 | +12.0% | 9,535 | +9.9% | 0.00% | – |
| Q4 2018 | $233,000 | -50.0% | 8,680 | -45.6% | 0.00% | – |
| Q3 2018 | $466,000 | +69.5% | 15,950 | +81.3% | 0.00% | – |
| Q2 2018 | $275,000 | – | 8,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |